EV71: an emerging infectious disease vaccine target in the Far East? (Q37715371)

22 August 2017

1 reference

title

EV71: an emerging infectious disease vaccine target in the Far East? (English)

1 reference

emerging communicable disease

22 August 2017

main subject

1 reference

1 reference

Juan Xu

1

1 reference

22 August 2017

Yuan Qian

2

1 reference

22 August 2017

Shixia Wang

3

1 reference

22 August 2017

Jill M Grimes Serrano

4

1 reference

22 August 2017

Wei Li

5

1 reference

22 August 2017

Zuhu Huang

6

1 reference

22 August 2017

Shan Lu

7

1 reference

22 August 2017

language of work or name

English

0 references

publication date

19 March 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

28

1 reference

22 August 2017

issue

20

1 reference

22 August 2017

page(s)

3516-3521

1 reference

Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Molecular Epidemiology of Human Enterovirus 71 Strains and Recent Outbreaks in the Asia-Pacific Region: Comparative Analysis of the VP1 and VP4 Genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Genetic and antigenic analyses of enterovirus 71 isolates in Taiwan during 1998-2005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Molecular strategy for 'serotyping' of human enteroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

The efficacy of viral capsid inhibitors in human enterovirus infection and associated diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

The VP1 structural protein of enterovirus 71 interacts with human ornithine decarboxylase and gene trap ankyrin repeat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Scavenger receptor B2 is a cellular receptor for enterovirus 71

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

The molecular basis of mouse adaptation by human enterovirus 71.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Antiviral activity of pyridyl imidazolidinones against enterovirus 71 variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

High-titred neutralizing antibodies to human enterovirus 71 preferentially bind to the N-terminal portion of the capsid protein VP1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Recombinant Newcastle Disease virus capsids displaying enterovirus 71 VP1 fragment induce a strong immune response in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Antibody recognition of picornaviruses and escape from neutralization: a structural view

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Direct identification of human enterovirus serotypes in cerebrospinal fluid by amplification and sequencing of the VP1 region.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Eight years of experience with molecular identification of human enteroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Molecular detection and characterization of human enteroviruses directly from clinical samples using RT-PCR and DNA sequencing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Revealing molecular targets for enterovirus type 71 detection by profile hidden Markov models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Genetic analysis of the VP1 region of Human enterovirus 71 strains isolated in Korea during 2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

RT-PCR, nucleotide, amino acid and phylogenetic analyses of enterovirus type 71 strains from Asia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Expression of capsid [correction of caspid] protein VP1 for use as antigen for the diagnosis of enterovirus 71 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

An apparently new enterovirus isolated from patients with disease of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Letter: New enterovirus type associated with epidemic of aseptic meningitis and-or hand, foot, and mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Virological diagnosis of enterovirus type 71 infections: Experiences gained during an epidemic of acute CNS diseases in Hungary in 1978

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Monoplegia caused by Enterovirus 71: an outbreak in Hong Kong

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Fatal enterovirus 71 encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Molecular characterization of an Enterovirus 71 causing neurological disease in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Epidemic of Hand, Foot and Mouth Disease Associated with Enterovirus 71 Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Neurologic complications in children with enterovirus 71 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Molecular epidemiology of enterovirus 71 in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Molecular epidemiology of enterovirus 71 in peninsular Malaysia, 1997-2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Enterovirus 71 outbreak in the People's Republic of China in 2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Enterovirus 71 outbreaks, Taiwan: occurrence and recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Pathogenicity of a poliomyelitis-like disease in monkeys infected orally with enterovirus 71: a model for human infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Neurovirulence in cynomolgus monkeys of enterovirus 71 isolated from a patient with hand, foot and mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

DNA vaccine constructs against enterovirus 71 elicit immune response in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.03.003

10.1016/J.VACCINE.2010.03.003

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference